Introduction
Chloride (Cl 2 ) ion flux across the plasma membrane, mediated by GABA-and glycine-activated Cl 2 channels, is an important modulator of neuronal excitability. During Cl 2 channel activation, the net direction of Cl 2 flux and the functional consequence of activation depend on the Cl 2 equilibrium potential, determined by the intracellular Cl 2 concentration ([Cl 2 ] i ). In immature neurons, [Cl 2 ] i is high and the Cl 2 equilibrium potential is positive to the resting potential, so that activation of GABA-or glycine-gated Cl 2 conductances results in membrane depolarization (Ben-Ari, 2002; Lu et al., 1999; Stein et al., 2004) . This Cl 2 conductance-induced membrane depolarization is sufficient to remove voltage-dependent Mg 2+ block of N-methyl-D-aspartate (NMDA) receptors (Ben-Ari, 2002; Lu et al., 1999; Stein et al., 2004) and increase intracellular calcium concentrations ([Ca 2+ ] i ), a potentially important trophic stimulus in immature neurons. During postnatal development, upregulation of KCC2, the K + -Cl 2 coupled cotransporter, decreases [Cl 2 ] i below its electrochemical equilibrium, resulting in a hyperpolarizing shift in the Cl 2 equilibrium potential (Ben-Ari, 2002) . Accordingly, activation of Cl 2 channels in mature neurons results in membrane hyperpolarization and decreased excitability.
In addition to ligand-gated anion conductances, members of the extensive CLC anion channel family have been identified within the central nervous system. Of these channels, CLC-3 is ubiquitously expressed throughout the central nervous system (Dickerson et al., 2002; Stobrawa et al., 2001; Yoshikawa et al., 2002) . CLC-3, when expressed at the plasma membrane, is unique among CLC channels, in that it is not constitutively active. Instead, CLC-3 is activated by calcium-calmodulin-dependent kinase II (CaMKII), which phosphorylates its N terminus (Huang et al., 2001; Robinson et al., 2004) .
Presynaptically, CLC-3 has been localized to synaptic vesicles, where it facilitates vesicular acidification prior to vesicle fusion with the plasma membrane (Stobrawa et al., 2001) . The postsynaptic localization of CLC-3 has not been described. Here, we describe a CaMKIIactivated Cl 2 conductance on the plasma membrane of cultured immature mouse and rat hippocampal neurons that is absent in clc-3 2/2 mice. This conductance is activated synaptically by NMDA receptor-induced [Ca 2+ ] i increases. Immunohistochemical studies demonstrate CLC-3 channel localization to the postsynaptic plasma membrane and colocalization with NMDA receptors. Comparison of synaptic activity from WT and clc-3 2/2 neurons demonstrates that CLC-3 channels enhance the time course of NMDA receptor-mediated excitatory post synaptic potentials. Thus, by means of Ca 2+ signaling, CLC-3 plasma membrane channels enhance the efficacy of NMDA-activated synapses at early times in postnatal neuronal development.
Results

Cultured Hippocampal Neurons Exhibit a CaMKII-Activated Cl
2 Conductance Whole-cell current recordings were obtained from hippocampal neurons cultured from P5 rats at 5-7 days in vitro. To clearly identify Cl 2 current activation, experiments were performed using solutions without permeant cations, where Cl 2 was the only permeant species. Asymmetric solutions (40 mM Cl 2 intracellular, 140 mM Cl 2 extracellular) were used to reproduce the intracellular Cl 2 concentration of immature neurons (BenAri, 2002). Basal current was determined immediately following whole-cell configuration and was negligible ( Figure 1A ). Coincident with diffusion of the autonomous kinase from the pipette into the neuron, test pulses induced a voltage-dependent current whose amplitude steadily increased over approximately 20-30 min ( Figure 1B ). Maximal current density at 20 min with a test pulse of +110 mV was 37.6 6 3.2 pA/pF (n = 31). Without CaMKII in the pipette, test pulses induced no current above basal levels. The current-voltage (I-V) relationship of I Cl, CaMKII was outwardly rectifying, with a reversal potential of approximately 216 mV (Figure 1C) . The difference between this potential and the theoretic reversal potential for Cl 2 under these ionic conditions (231 mV) indicates some permeability of the conductance to glutamate, used as a Cl 2 substitute in the internal pipette solution.
To confirm that the induced current was activated by CaMKII, we added autoinhibitory peptide (AIP, 1 mM), a specific CaMKII inhibitor (Ishida et al., 1995) , to the pipette solution along with the autonomous CaMKII. The presence of AIP completely blocked activation of the CaMKII-induced currents (n = 3). To exclude the possibility that CaMKII indirectly activated this Cl 2 channel through release of Ca 2+ , we clamped [Ca 2+ ] i with BAPTA (10 mM) in the pipette solution and measured autonomous kinase-induced Cl 2 currents. The resultant I Cl, CaMKII amplitude (34.2 6 4.5 pA/pF, n = 5) was not significantly different from that obtained when internal free Ca 2+ levels were buffered to 40 nM with 1mM EGTA and 0.2 mM Ca 2+ ( Figure 1D ). The only previously reported CaMKII-activated conductance at the molecular level is CLC-3, a member of the CLC family of voltage-gated chloride channels, which we have previously shown gives rise to outwardly rectifying CaMKII-dependent Cl 2 currents when expressed at the plasma membrane (Huang et al., 2001 ). In addition to being activated by CaMKII, the anion conductance in hippocampal neurons exhibited biophysical properties identical to that of recombinant CLC-3, including (1) an outwardly rectifying current-voltage relationship, (2) the identical halide anion selectivity series (I 2 > Cl 2 ; see Figure S1 in the Supplemental Data available with this article online), and (3) inhibition of both inward and outward CaMKII-activated currents by the Cl 2 channel blocker DIDS (100 mM; percent inhibition, 75 6 10% at 110 mV; 52 6 9% at 2110mV, n = 3; Figure S1 ). Thus, the biophysical signature of this anion conductance in hippocampal neurons was identical to that exhibited by recombinant CLC-3.
Single CaMKII-Activated Channel Recordings Reveal Two-Pore Activity Members of the CLC chloride channel family are typified by having a two-pore structure whereby each pore conducts independently of the second pore and gating is controlled by a mechanism involving both a fast and slow gate (Ludewig et al., 1996 (Ludewig et al., , 1997 Middleton et al., 1996; Miller, 1982) . To assess whether the hippocampal CaMKII-activated anion conductance demonstrated two-pore behavior, we recorded activity of single CaMKII-activated channels from inside-out patches taken from P5 hippocampal rat neurons (Figure 2A ). Current recordings were obtained at potentials between 280 and +100 mV. Channels were activated by perfusing the intracellular face of the patch with autonomous kinase, using a pipette positioned 5-10 mm from the patch pipette. In the presence of autonomous kinase, we consistently observed two amplitudes of channel activity, (A) Representative voltage-clamp recording of a P5 hippocampal rat neuron immediately following establishment of whole-cell configuration (Basal) and following peak current activation after diffusion of CaMKII into the cell (CaMKII). Currents were elicited during a series of test pulses from 2110 to +110 mV in 10 mV increments from a holding potential of 240 mV. (B) Time course of current activation. Cells were allowed to equilibrate for approximately 4 min prior to current recording. Diffusion of the autonomously active CaMKII from the pipette into the cell gradually activates a Cl 2 current that plateaus at about 20 min. (C) The averaged I-V relationship from all cells examined (n = 31) shows significant outward rectification, with the reversal potential about 216 mV. (D) Summary of pharmacology of the CaMKIIactivated current. Cl 2 current was not recorded in the absence of CaMKII in pipette solution (n = 5). AIP (autoinhibitory peptide), a specific CaMKII inhibitor, inhibited current activation by CaMKII (n = 3) when included in the pipette solution; BAPTA did not inhibit the autonomous kinase-activated current (n = 5), demonstrating that current activation was not the result of Ca 2+ release from internal stores.
consistent with the activity of two pores, beginning within 20 ms of CaMKII application ( Figure 2B ). All points amplitude histograms of channel activity were constructed. In the absence of CaMKII, no channel activity was observed ( Figure 2C, top) . In the presence of CaMKII, equal open state probabilities were observed for both pores, typical of CLC channels (Lin et al., 1999; Nobile et al., 2000; Pusch et al., 2001; Saviane et al., 1999; White and Miller, 1979) . When the autoinhibitory peptide (1 mM) was perfused onto patches with autonomous kinase, channel activity was absent ( Figure 2C , bottom). Current-voltage relationships for the two amplitude peaks were constructed from data obtained from four patches ( Figure 2D ): the conductance of the first peak was 3.33 6 0.07 pS ; the conductance of the higher peak was 6.53 6 0.22 pS, approximately double the conductance of the first.
CaMKII-Activated Cl
2 Currents Are Absent in Hippocampal Neurons from clc-3 2/2 Mice As described above, the CaMKII-activated anion conductance we recorded in hippocampal neurons exhibited the identical biophysical signature when compared to the recombinant CLC-3 conductance. In order to establish unequivocally that this conductance is mediated by CLC-3, investigators, unaware of the genotype of the cultured neurons, recorded CaMKII-activated anion conductances from hippocampal neurons cultured from 5-day-old WT and clc-3 2/2 mice, using techniques identical to those used to culture postnatal rat neurons ( Figure 3A) . Resting membrane potential, membrane time constant, input resistance, and membrane capacitance did not differ between WT and clc-3 2/2 neurons ( Figure 3B ). In neurons from WT mice, Cl 2 current was present in all neurons studied, with current density ranging between 10 and 45 pA/pF, (mean current density 22.6 6 3.9 pA/pF, n = 10). In contrast, CaMKII-activated currents were absent in all neurons from clc-3 2/2 mice (n = 11). These data confirm that the CaMKII-activated anion conductance in hippocampal neurons is mediated by CLC-3 channels.
To understand the role played by the CaMKII-activated Cl 2 conductance in regulating neuronal excitability, we systematically altered E Cl 2, using intracellular solutions of different Cl 2 concentrations, and measured the amplitude and time course of spontaneous miniature excitatory synaptic potentials (mEPSPs) in the presence of tetrodotoxin and picrotoxin. 2/2 and clc-3 +/+ cultured mouse hippocampal neurons. Currents were recorded according to the voltage protocol in Figure 1 and were recorded in the presence of autonomously active CaMKII (1 mg/ml) introduced into the cell via the patch pipette. Right: Current density comparison of CaMKII-mediated Cl 2 current activation in cultured clc-3 2/2 (0, n = 11) versus WT (22.60 6 3.93, n = 10) hippocampal P5 neurons. (B) Comparison of the basic membrane properties between WT and clc-3 2/2 cells. Upper panel: voltage protocol, raw potential traces, and V-I curve used to calculate membrane parameters. Membrane potential was determined in perforated patch experiments. Input resistance was determined from the amplitude of a series of current injections. Resultant voltages were plotted as a function of current and the slope of the relationship used to calculate the input resistance. Capacitance was determined from the time constant of the decay of the capacity transient and the value of the input resistance. Bottom panel: Comparisons of membrane potential, membrane time constant, input resistance, and capacitance between neurons from WT (black) and clc-3 2/2 mice (stippled). Membrane potential (perforated patch) for WT (55.34 6 1.62 mV, n = 5) and KO (52.38 6 2.33 mV, n = 8); membrane time constant for WT (35.14 6 2.23 ms, n = 49) and KO (33.92 6 3.89 ms, n = 28); membrane resistance for WT (461 6 32 MU, n = 49) and KO (437 6 36 MU, n = 28); and membrane capacitance for WT (79.55 6 2.74 pF, n = 49) and KO (75.27 6 4.51, n = 28). (C) Averaged mEPSPs from single neurons in three different internal Cl concentrations from WT (black) and clc-3 2/2 (red) mice. (D) Mean mEPSP amplitudes (D) and decay time constants (E) obtained in the same internal Cl 2 concentrations as in (C), above, from WT (black) and clc-3 2/2 (red) mice. Membrane potential was 260 mV in all of the recording conditions. Error bars (6 SEM) for the mean data are within the symbols.
solutions in P5 cultured hippocampal neurons from WT and clc-3 2/2 mice at two different Cl 2 equilibrium potentials. Under conditions in which E Cl 2 = 280 (internal [Cl 2 ] set at 5 mM, reflecting the mature neuron, Figure 4A ) currents in the WT cells were decreased compared with those observed in the KO cells throughout the voltage range. In addition, the current reversal potential for the wild-type cells was shifted by 218 mV relative to that seen in the KO neurons. These data are consistent with a model of mature neurons in which the activation of CLC-3 is inhibitory and the contribution of the Cl 2 conductance underlying the NMDA conductance left shifts the reversal potential.
In contrast, when E Cl was set at 231 mV (internal [Cl 2 ] set at 40 mM), typical of immature neurons, the WT current was consistently larger than the current in the clc-3 2/2 neurons ( Figure 4B ). Consistent with the contribution of a Cl 2 conductance, the reversal potential in the WT neurons was left shifted compared with clc-3 2/2 neurons, but only by 7 mV. Thus, Ca 2+ influx via NMDARs activates CaMKII, leading to activation of the CLC-3 channel and, in immature neurons, enhancing membrane excitability.
CLC-3 Is Expressed at the Synaptic Plasma Membrane in Hippocampal Neurons
Our recording of CLC-3 currents in hippocampal neurons provides electrophysiological evidence that a population of CLC-3 localizes to the plasma membrane. We verified plasma membrane expression biochemically in biotinylation experiments. Using a membrane-impermeant biotin derivative (NHS-LC-LC-Biotin), we biotinylated plasma membrane proteins exposed on the extracellular surface of cultured embryonic hippocampal neurons. Upon cell lysis, biotinylated proteins were captured onto streptavidin-coated beads and separated by SDS-PAGE, followed by Western blot analysis using anti-CLC-3 [730] [731] [732] [733] [734] [735] [736] [737] [738] [739] [740] [741] [742] [743] [744] . Incubation of the biotinylated proteins with anti-CLC-3 revealed a band at 90 kDa, the predicted molecular weight for CLC-3. This band was not seen in the eluate in the absence of biotinylation ( Figure 5A ).
To obtain additional confirmation that CLC-3 localizes to the plasma membrane, we assayed for CLC-3 expression in synaptic (synaptosomal) plasma membranes. Because CLC-3 expression has been previously established in synaptic vesicles (Stobrawa et al., 2001) , we separated synaptic vesicles from synaptosomal membranes by lysing synaptosomes in hypotonic buffer then purifying synaptic plasma membranes. As expected, CLC-3 expression was observed in isolated synaptic vesicles, identified by synaptotagmin expression ( Figure 5B ). The identity of synaptic plasma membranes was confirmed with staining for ATPase a1; the absence of contaminating synaptic vesicles in this preparation was confirmed by the absence of synaptotagmin immunoreactivity. In this plasma membrane preparation, CLC-3 was strongly expressed ( Figure 5B ).
To directly visualize CLC-3 localization on plasma membranes, we performed immunoelectron microscopy 2) in the case where E Cl was set at 280 mV. When E Cl was set at 230 mV, the pipette solution contained 100 KMeSO 4 and 40 KCl. Ca 2+ in the pipette solutions was calculated to be 40 nM. Currents were corrected for liquid junction potentials.
of lysed synaptic plasma membranes. Synaptic plasma membranes exhibited marked PSD-95 immunoreactivity, a component of the postsynaptic density. Immunogold staining of these PSD-95-immunoreactive synaptosomes for CLC-3 revealed CLC-3 immunoreactivity of the same structures ( Figure 5C ), demonstrating CLC-3 localization to postsynaptic plasma membranes. Staining with preimmune IgG did not demonstrate labeling ( Figure 5D ).
CLC-3 Is Expressed at Postsynaptic Sites
Having obtained electron microscopic evidence that CLC-3 localizes to postsynaptic membranes in synaptosomal membrane preparations, we asked whether CLC-3 localization on the plasma membrane is similarly restricted to synapses in intact neurons. We employed an antibody to an extracellular domain of CLC-3 (CLC-3 Ex ; Wang et al., 2003) and stained neurons prior to permeabilization. Under these conditions of extracellular staining, CLC-3 immunoreactivity was sparse and punctate, primarily staining dendrites, although somal puncta were also visible. To assess whether these immunoreactive puncta colocalized with synapses, we performed confocal imaging of neurons that had been double immunostained for extracellular CLC-3 and either PSD-95 ( Figure 6A ) or NMDAR1 ( Figure 6B ). Confocal imaging of these staining patterns revealed remarkable colocalization, especially in neurites, indicating localization of CLC-3 at synapses. Because CLC-3 colocalized with postsynaptic proteins and with postsynaptic plasma membranes, we assessed whether CLC-3 was physically associated with postsynaptic proteins. Physical association was determined using coimmunoprecipitation. CLC-3 was first immunoprecipitated from purified, lysed synaptosomal plasma membranes free of synaptic vesicles. The immunoprecipitates were then probed for the presence of postsynaptic proteins. CLC-3 immunoprecipitates demonstrated clear immunoreactivity for PSD-95, NMDAR1, and NMDAR2B ( Figure 6C ). Immunoprecipitates of PSD-95 similarly demonstrated CLC-3 immunoreactivity. Importantly, Na + -K + ATPase a1, a key extrasynaptic component of postsynaptic plasma membranes, was not found in CLC-3 immunoprecipitates ( Figure 6C) ; in like fashion, immunoprecipitates of Na + -K + ATPase a1 contained no CLC-3 immunoreactivity. These control experiments demonstrate specificity of the coimmunoprecipitation procedure for synaptic proteins. Taken together, the colocalization of CLC-3 with postsynaptic proteins and the coimmunoprecipitation of CLC-3 and the same (A) Primary cultured neurons were surface biotinylated with membrane impermeable, thiol-cleavable NHS-LC-LC-Biotin, lysed in RIPA buffer, and incubated with streptavidin-coated agarose beads. Surface-biotinylated proteins were eluted from the beads, separated by SDS-PAGE, and detected on the western blot by anti-CLC-3 730-744 . PBS was used as a negative control. (B) Western blot of synaptic vesicles (SV) and synaptosomal membranes (SM) obtained as previously described (Huttner et al., 1983) . Na postsynaptic proteins indicate that CLC-3 is located at postsynaptic sites. It is likely that the interaction of CLC-3 with PSD-95 and NMDA receptor subunits is mediated indirectly through interactions within the PSD.
CLC-3 Expression Decreases the Time Course of Spontaneous EPSP Decay
Having determined the Cl dependence of NMDA receptor potentials and currents, we assessed the contribution made by CLC-3 to NMDA receptor-mediated mEPSPs in immature (P5) neurons. In order to preserve native intracellular Cl concentrations, we used the perforated patch technique and compared mEPSP amplitudes and kinetics in hippocampal neurons cultured from WT and clc-3 2/2 mice. mEPSPs were primarily sensitive to MK-801 (10 mM), leaving occasional fastinactivating, CNQX-sensitive mEPSPs ( Figure 7A ). These data indicate that the majority of mEPSPs were mediated by NMDA receptor activation.
In neurons from WT mice, the mean decay time constant was 24.6 6 2.8 ms (429 mEPSPs in five neurons), almost twice the length of the time constant observed in neurons from clc-3 2/2 mice (13.6 6 1.4 mS; 1526 mEPSPs from seven neurons, p < 0.01; Figures 7B and  7C ). The severely shortened mEPSP decay time constant in clc-3 2/2 mice confirms that, in immature neurons, CLC-3 channels increase the time the postsynaptic membrane remains depolarized during excitatory synaptic activity, increasing synaptic strength. Neurons from clc-3 2/2 mice also exhibited significantly smaller mean mEPSP amplitudes (1.39 6 0.02 mV, n = 1616 from eight neurons) versus WT (2.27 6 0.07 mV, n = 339 from five neurons, p < 0.001), and a cumulative event histogram that was significantly left-shifted as compared with the histogram from WT mice ( Figure 7D ).
In order to determine whether the differences in mEPSP amplitude and kinetics could be accounted for by the difference in dendritic development in WT and clc-3 2/2 neurons, we compared dendrite development in P5 WT and clc-3 2/2 neurons at 6 days in vitro. We visualized dendrites using MAP2 immunostaining. Lengths of first-, second-, and third-order dendrites were traced and measured by an investigator unaware of genotype. Statistical testing revealed a significant dependence of dendrite length on dendrite order (p < 0.001), such that first-order dendrites > second-order dendrites > third-order dendrites. However, there was no significant difference between dendrite lengths between WT and KO mice (p = 0.1, n = 206 dendrites WT, 144 dendrites KO). These data are submitted as Figure S2 . Thus, while, in principle, the differences in EPSP amplitude and decay time could be due to potential dendritic filtering effect, in fact, we found that there was no difference in dendrite length between clc-3 2/2 and WT mice. (Wang et al., 2003) binds to the extracellular region of CLC-3 and therefore only recognizes the membrane population of CLC-3 and not the intracellular vesicular fraction. The overlay image shows colocalization of CLC-3 and PSD-95 at the synaptic plasma membrane. (B) Immunofluorescent staining with anti-NR1 and anti-CLC-3 Ex demonstrates colocalization of NR1 (a postsynaptic plasma membrane protein) and CLC-3 at the plasma membrane of rat hippocampal neurons at the synaptic sites. (C) Association of CLC-3 with PSD-95 and NMDAR 1/2B. CLC-3 was immunoprecipitated from synaptosomal membrane preparations, and proteins were resolved by SDS-PAGE. Immunoblotting was performed with anti-PSD-95, anti-NR2B, and anti-NR1 (see Experimental Procedures) (1, 2, 4). In order to evaluate the specificity of CLC-3 interaction with the postsynaptic proteins, coimmunoprecipitation was also performed using antibodies against the nonsynaptic protein, Na + -K + ATPase a1 (6). Coimmunoprecipitation was also performed in a reciprocal way: anti-PSD-95 and anti-Na + -K + ATPase a1 were used to pull down CLC-3 that was detected on the blot with anti-CLC-3 (3, 5). CLC-3 did not associate with Na + -K + ATPase a1, which is found in the synaptosomal membrane fraction and was used as a marker of the plasma membrane to confirm enrichment of the fraction. Samples taken before immunoprecipitation (Pre-IP) were detected with both antibodies to demonstrate the presence of both proteins. ] i increases should prevent CaMKII-induced activation of CLC-3. Hence, a high affinity intracellular Ca 2+ chelator should alter mEPSP decay kinetics in a manner similar to that seen in clc-3 2/2 neurons. Accordingly, we recorded mEPSPs in cultured P5 mouse hippocampal neurons in the presence and absence of BAPTA (10 mM). We used apamin (100 nM) to eliminate the confounding effect of small conductance Ca 2+ -activated K + (SK) channel activity on mEPSP amplitude (Faber et al., 2005; Ngo-Anh et al., 2005) . Whole-cell recordings were made using pipette solutions containing 40 mM Cl 2 . In WT, untreated neurons, the mean EPSP amplitude was 1.39 6 0.02 mV (2002 mEPSPs from five neurons), significantly larger than the mean amplitude observed in neurons from clc-3 2/2 mice (0.708 6 0.009 mV, n = 1668 from 10 neurons). Addition of BAPTA to the pipette in WT neurons reduced mEPSP amplitude to the same extent as the clc-3 2/2 mice (0.704 6 0.005 mV, n = 6412 from six neurons). In clc-3 2/2 mice, BAPTA had no effect on mEPSP amplitude (0.760 6 0.007 mV, n = 3851 from 10 neurons).
CLC-3 Channels
Similarly, the mean mEPSP decay time constant in WT, untreated neurons was 33.28 6 1.68 ms (n = 5), significantly longer than that observed in clc-3 2/2 mice (13.37 6 0.60 ms, n =10). Addition of BAPTA to WT neurons similarly decreased the mean mEPSP decay time constant to the same extent as the clc-3 2/2 mice (16.25 6 0.19 ms, n = 6). BAPTA treatment of clc-3 2/2 neurons somewhat increased mEPSP decay time over untreated neurons (clc-3 2/2 13.37 6 0.60 ms, n = 10; clc-3 2/2 plus BAPTA 27.52 6 0.47 ms, n = 10), but remained significantly decreased compared with untreated WT neurons (p < 0.05) . Accordingly, the Ca 2+ dependence of NMDA receptor-mediated mEPSP amplitude and decay time constant is consistent with modulation of EPSP kinetics by CLC-3 activity. It also provides functional evidence of close spatial coupling between CLC-3 channels and NMDA receptors.
Discussion
The central finding of this work is that voltage-activated Cl 2 channels on the postsynaptic plasma membrane alter the excitability of immature hippocampal neurons. No voltage-activated Cl 2 channel has been previously reported to alter neuronal excitability. NMDA receptorinduced Ca 2+ influx activates CaMKII, opening CaMKIIactivated CLC-3 channels. Because [Cl 2 ] i is higher than its electrochemical equilibrium at this stage of postnatal development (Ben-Ari, 2002; Lu et al., 1999; Stein et al., 2004) , opening of CLC-3 channels would be predicted to depolarize the membrane, prolonging the NMDA-mediated EPSP. In fact, our data demonstrate precisely this modulation of excitability upon CLC-3 activation. Hence, prior to the developmental upregulation of KCC2 expression (Ben-Ari, 2002 ) and the resultant decrease in [Cl 2 ] i to below its electrochemical equilibrium, neuronal CLC-3 channels amplify the excitability increase of NMDA receptor activation.
To identify this anion conductance electrophysiologically, we used solutions that ensured that Cl 2 was the primary charge carrier. The dependence of this outwardly rectifying, noninactivating conductance on CaMKII for activation, together with its inhibition by both the specific peptide CaMKII inhibitor and the Cl 2 channel inhibitor DIDS exactly match the properties of recombinant CLC-3 (Huang et al., 2001; Robinson et al., 2004) , the only reported CaMKII-activated conductance (anion or cation). The absence of this neuronal conductance in clc-3 2/2 mice, but not in otherwise identical WT mice, conclusively identifies this conductance as CLC-3.
CLC-3, a member of the CLC family of voltage-activated Cl 2 channels, is strongly expressed in brain. We obtained electrophysiological, biochemical, immunohistochemical, and electron microscopic evidence of CLC-3 localization to the neuronal plasma membrane. First, whole-cell patch clamp studies demonstrated a CLC-3-mediated anion conductance on the neuronal membrane. Next, cell surface proteins isolated with extracellular biotinylation exhibited CLC-3 immunoreactivity. Finally, lysed synaptosomal membranes, a synaptic plasma membrane preparation that we have demonstrated, by the absence of synaptotagmin immunoreactivity, to be free of synaptic vesicles, also demonstrates CLC-3 immunoreactivity. Taken together, these data demonstrate that CLC-3 is present on the neuronal plasma membrane and is present on synaptic plasma membranes. Previous studies of the effect of knocking out CLC-3 on membrane Cl 2 currents have been limited to finding no differences in swelling-induced Cl 2 currents between cells from WT and clc-3 2/2 mice (Stobrawa et al., 2001) . Taking advantage of CLC-3's unique activation by CaMKII, we have demonstrated not only the plasma membrane localization of CLC-3, but also the role of CLC-3 in modulating neuronal excitability.
There is ample evidence that voltage-activated Cl 2 conductances contribute to the genesis of the membrane potential (Madison et al., 1986; Sacchi et al., 1999; Staley, 1995) . By extension, such Cl 2 conductances have been assumed to be able to modulate neuronal excitability. However, the molecular identity, localization, and mechanisms of activation of these conductances have remained unclear. The identification of CLC-3 as a modulator of neuronal excitability identifies a new role for a class of channels previously believed to function as passive regulators of Cl 2 concentration. Calcium-dependent Cl 2 conductances have been characterized as contributing to slow after-depolarization following spike trains (Currie et al., 1995) and as being activated following axotomy (Sanchez-Vives and Gallego, 1994) . Single-channel recordings of these conductances in cultured rat hippocampal and cortical neurons have found these conductances to be constitutively active and to demonstrate states consistent with a single pore (Blatz, 1991; Franciolini and Nonner, 1987) . In contrast, our single-channel recordings of CLC-3 conductance demonstrated two-pore behavior, consistent with previous studies of single-channel activity for members of the CLC anion channel family.
The striking colocalization of the synaptic markers PSD-95 and NMDAR1 with CLC-3 by confocal microscopy provides additional evidence of synaptic localization of CLC-3 in intact hippocampal neurons. By using an antibody to an extracellular epitope of CLC-3 and applying it to living, intact neurons, we restricted antibody binding to plasma membrane-resident CLC-3. Because light microscopy cannot distinguish between CLC-3 localization at the presynaptic or postsynaptic membrane, we performed double, gold-tagged immunohistochemistry of PSD-95 and CLC-3 on lysed synaptic membranes and imaged staining patterns with electron microscopy. Our finding of PSD-95 and CLC-3 immunoreactivity on the same membranes demonstrates (1) the postsynaptic nature of the membranes and (2) the localization of CLC-3 to these postsynaptic plasma membranes. Furthermore, our finding of PSD-95 and NMDAR1 immunoreactivity in CLC-3 proteins immunoprecipitated from lysed synaptic membranes further supports the notion that CLC-3 is localized to postsynaptic sites and, in particular, to the postsynaptic density.
CLC-3 has been also well documented to be on synaptic vesicles (Stobrawa et al., 2001 ). Functionally, studies employing clc-3 2/2 mice have identified a role for CLC-3 in Cl 2 -mediated acidification of synaptic vesicles and subsequent uptake of glutamate. In our studies of mEPSPs in clc-3 2/2 and WT mice, we also observed a left-shifted cumulative event histogram in clc-3 2/2 neurons. However, the similarity of the decrease in mEPSP amplitude seen in BAPTA-treated WT neurons and clc-3 2/2 neurons strongly suggests that the differences in EPSPs between KO and WT mice are postsynaptic in origin. The localization of CLC-3 to the postsynaptic side of NMDAergic synapses suggested that CLC-3 modulates NMDA-mediated mEPSPs. mEPSPs from the clc-3 2/2 neurons had a significantly shorter time course than that observed in the neurons from the WT animals at the same age and membrane potential. Importantly, the absence of significant differences in steady-state membrane resistance and capacitance between the WT and clc-3 2/2 neurons support the observation that the difference in membrane time constants between clc-3 2/2 and WT neurons was minimal. Thus, the greater time constants of mEPSP decay we observed in neurons from WT mice compared with those from clc-3 2/2 mice is inconsistent with the decreased input resistance that accompanies the activation of the CLC-3 conductance. Instead, our data demonstrate that CLC-3 activation in these developing neurons prolongs synaptically activated NMDA-activated mEPSPs. This conclusion is further reinforced by our mEPSP recordings comparing clc-3 2/2 and clc-3
neurons in the presence of BAPTA: blockade of CaMKII with BAPTA in the patch pipette resulted in similar decreases in mEPSP amplitude and time constant of decay, an effect that cannot be due to modulation of the presynaptic neuron. How might CLC-3 activation at synapses prolong NMDA receptor-activated mEPSPs at this early developmental stage? Taken together, our data support a model ( Figure 8B ) in which Ca 2+ entry across the postsynaptic membrane promotes CaMKII activation of CLC-3. However, whether CLC-3-induced membrane depolarization reduces Mg 2+ block of NMDA receptors or whether CLC-3 current itself is sufficient to induce depolarization is not apparent. In any case, the increase in the time course in mEPSP decay may enhance synaptic efficacy in generating action potentials and in inducing Ca 2+ influx via the opening of voltage-gated Ca 2+ channels.
Experimental Procedures Animals
Five-day-old (P5) Sprague Dawley rats and day 18 embryonic (E18) rat fetuses from timed pregnancies were used. For knockout studies, we used P5 clc-3 2/2 mice (Dickerson et al., 2002) and C57Bl/ 6J-SV129 background and littermate WT mice as controls. For genotyping, genomic DNA was extracted from the tails of P5 pups at the time of culture using REDExtract-N-Amp Tissue PCR Kit (Sigma). Genotyping was performed by PCR using primers specific for the WT allele (forward, 5 0 -TACATGTTGCCTGCTGCTGT-3 0 ; reverse, 5 0 -CTGCAGCACTCAACTCCAGA-3 0 ) and primers specific for the knockout allele (forward, 5 0 -TGAATGAACTGCAGGACGAG-3 0 ; reverse, 5 0 -ATACTTTCTCGGCAGGAGCA-3 0 ; Dickerson et al., 2002) . Thirty-five cycles of PCR were performed at following conditions: denaturation at 94 C for 2 min, annealing at 57 C for 30 s, extension at 68 C for 1 min.
Antibodies Anti-CLC-3 was produced (Quality Controlled Biochemicals) from a synthetic peptide corresponding to amino acids 730-744 of human CLC-3, with an additional alanine and glutamic acid (GSSRVCFAQHTPSLPAE). Specificity of the antibody for CLC-3 has been previously reported (Huang et al., 2005) . Dr. Joseph R. Hume kindly provided the affinity purified, polyclonal antibody to an extracellular loop of a transmembrane portion of CLC-3 (Wang et al., 2003) . The mouse monoclonal anti-NMDAR1 was obtained from Chemicon. The mouse anti-PSD-95 was from Affinity Bioreagents. Anti-Na-K ATPase a was obtained from Upstate and antisynaptotagmin from BD Biosciences. Alexa 488-conjugated goat anti-rabbit and rhodamine-conjugated goat anti-mouse IgG were from Molecular Probes-Invitrogen. Rhodamine-conjugated rabbit anti-sheep IgG was from ICN. Horseradish peroxidase-conjugated goat anti-mouse IgG and donkey anti-rabbit IgG were from Promega and Amersham, respectively. Goat anti-rabbit and goat anti-mouse IgG conjugated to 15 nm and 10 nm gold particles, respectively, were obtained from Ted Pella.
Neuronal Cultures
We have previously used hippocampal neurons cultured from E17-P30 animals as a model of postnatal development (Marks et al., 2005; Marks et al., 2000) . Briefly, isoflurane-anesthetized rats or mice were decapitated, the hippocampi removed, sectioned (400 mM), and incubated in oxygenated, pH-buffered saline. Sections were incubated at room temperature with papain for 30 min then protease (0.4 mg/ml) for 15 min. Slices were placed into a microcentrifuge tube containing 1 ml Hybernate A and mechanically triturated with a series of 2-4 fire-polished Pasteur pipettes with progressively decreasing mouth diameters. Dissociated cells were centrifuged through an iodixanol density gradient (1.055-1.026 g/ ml) at 1900 rpm for 15 min, and the resultant pellet suspended in the most inferior aqueous fraction. DNase (175 U/ml) was added to facilitate dispersion, and 200 ml aliquots plated onto poly-lysinecoated coverslips. Coverslips were placed on a layer of cultured cortical astrocytes, maintained in DMEM supplemented with 4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid HEPES, 15 mM, N 2 , and ovalbumin. Cells were incubated in a humidified atmosphere containing O 2 (5% 6 0.1%) and CO 2 (5% 6 0.1%), balance N 2 at 32 C by means of a servo-controlled tri-gas incubator (Hereus) connected to CO 2 and O 2 tanks. The O 2 partial pressure in the incubator was continuously measured with a Clarke electrode and the O 2 and CO 2 set points maintained by flushing the incubator with N 2 and CO 2 , respectively. For experiments employing clc-3 2/2 mice, genotypic purity of the cultures was ensured by separately dissociating and culturing hippocampi from individual identified pups. Immunostaining for the neuron-specific marker NeuN, as well as for oligodendrocyte-and astrocyte-specific markers, demonstrated that these cultures contained >98% neurons (data not shown).
Electrophysiology
Whole-Cell Voltage-Clamp Recordings Patch-clamp recordings from cultured hippocampal neurons were made using quartz pipettes and an EPC-9 amplifier (HEKA Elektronik). Extra-and intracellular solutions were designed such that Cl 2 was the primary charge carrier. The bath solution contained 140 mM HCl, 140 mM N-methyl D-glucamine, 2 mM CaCl 2 , 1 mM MgCl 2 , and 10 mM HEPES (pH 7.4). The pipette solution contained 40 mM HCl, 100 mM L-glutamic acid, 140 mM N-methyl D-glucamine, 0.2 mM CaCl 2 , 2 mM MgCl 2 , 1 mM EGTA, 10 mM HEPES, and 2 mM ATP-Mg (pH 7.2). Free Ca 2+ was calculated to be 40 nM. Ca 2+ -independent, autonomously active, autophosphorylated CaMKII was prepared daily from purified rat brain CaMKII as previously described (Huang et al., 2001) and introduced into the cell via the patch pipette. The Cl 2 equilibrium potential was calculated to be 231 mV. Under these ionic conditions, nonspecific leak current was identified as a depolarizing shift in reversal potential. Currents were elicited using a series of test pulses from 2110 to +110 mV in 10 mV increments from a holding potential of 240 mV. Test pulses (200 ms) were delivered at 2 s intervals. Current recordings were acquired at 2 kHz and filtered at 1 kHz. To induce fast internal Ca 2+ buffering, 10 mM BAPTA was, in some experiments, substituted for EGTA, and the CaCl 2 removed. In these experiments, the pipette solution contained 104 mM K + methanesulfonate, 26 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 10 mM BAPTA 10, 10 mM HEPES, and 3.5 mM Mg 2 -ATP (pH 7.2). The external solution contained 136 mM NaCl, 2.5 mM KCl, 10 mM HEPES, 10 mM D-glucose, 2 mM CaCl 2 , and 1.3 mM MgCl 2 (pH 7.4).
Recordings of Spontaneous Postsynaptic Potentials
In neurons from KO and WT mice, spontaneous mEPSPs were acquired in the perforated patch configuration using 50 mg/ml gramicidin (Sigma) in a pipette solution containing 150 mM KCl and 10 mM HEPES (pH 7.4). In experiments where either [Cl 2 ] i. was set or where cell-impermeant constituents (AIP or BAPTA) were introduced, whole-cell recordings were made. The bath solution in these experiments contained 136 mM NaCl, 2.5 mM KCl, 10 mM HEPES, 10 mM D-glucose, 2 mM CaCl 2 , 1.3 mM MgCl 2 , 0.5 mM tetrodotoxin, and 100 mM picrotoxin (pH 7.4). In some experiments (see text), small conductance Ca 2+ -activated K + channels were blocked with apamin (100 nM). Brief, negative 10 mV voltage steps were repeatedly applied to monitor changes in input resistance and capacitance for 15-20 min. Spontaneous mEPSP recordings were acquired and stored digitally using the data acquisition/analysis package PULSE (HEKA Electronik). Potential recordings were acquired at 6 kHz and filtered at 3 kHz. We used MiniAnalysis 6 (Synaptosoft) to detect mEPSP events, create cumulative amplitude histograms of the pooled data, and fit decay times of the events. mEPSPs from single cells were averaged, and the decay fit with a single exponential.
Single-Channel Recordings
Single-channel recordings were made using inside-out patches. The pipette solution used in whole patch-clamp experiments was used as the bath solution in the single-channel studies; however, the Cl 2 concentration in these experiments was elevated to 140 mM. Similarly, the bath solution used in the whole-cell patch-clamp experiments (Cl 2 140 mM) was used as the pipette solution. The autonomous, autophosphorylated CaMKII was delivered to the inner surface of the patch using a DAD-12 drug perfusion system (Adams-List, Westbury, NY). Single channel currents were digitally sampled at 1.6 kHz and filtered at 800 Hz. Current traces were displayed and stored digitally and analyzed offline using the singlechannel analysis program TAC (Bruxton Corp.).
All results are expressed as mean 6 standard error of the mean (SEM). Student's t test was used to test for significant differences. All experiments were performed at room temperature.
Immunocytochemistry
Cells cultured on coverslips were rinsed three times with phosphatebuffered saline (PBS). Nonspecific binding sites were blocked in PBS containing goat serum (2%), bovine serum albumin (0.5%), and sucrose (4%). Living neurons were incubated overnight at 4 C with anti-CLC-3 Ex (1:400) then fixed in paraformaldehyde 4% for 30 min at 4 C. Neurons were permeabilized with Triton X-100 (0.1%) for 3 min at 4 C. After 1 hr blocking, cells were incubated with mouse monoclonal anti-NMDAR1 (1:1000) or sheep anti-PSD-95 (1:200). Primary antibody binding was amplified and visualized with Alexa 488-conjugated goat anti-rabbit antibody (1:2000) for anti-CLC-3, rhodamine-conjugated goat anti-mouse IgG (1:4000) for NMDAR1, and rhodamine-conjugated rabbit anti-sheep IgG (1:2000) for anti-PSD-95. Coverslips were mounted and observed with a 603, 1.40 NA objective and imaged with a confocal microscope (Fluoview, Olympus).
Surface Biotinylation
Biotinylation of plasma membrane proteins having an extracellular domain was performed on cultures of hippocampal neurons from E18 Sprague-Dawley rats, using a water-soluble, membrane impermeant, and thiol-cleavable biotin reagent, as described previously (Davis et al., 1998) with minor modifications. Biotinylation was performed directly in the culture dish. Neuronal cultures were rinsed with ice-cold PBS (pH 7.4) and incubated with EZ-link Sulfo-NHS-LC-LC-Biotin (3 mg/ml, Pierce) in PBS containing 0.1 mM CaCl 2 and 1mM MgCl 2 , (pH 8.0) for 30 min at 4 C. Biotinylation was terminated by adding 10mM Tris (Tris(hydroxymethyl)aminomethane) (pH 8.5) for 5 min at 4 C, followed by three rinses with PBS containing Tris, 10 mM to quench unbound biotin. Cells were harvested and lysed in modified RIPA buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 1% Igepal CA-630, 10 mM NaMoO 4 ) with 0.2% protease inhibitor cocktail (Sigma) for 1 hr at 4 C. The lysate was centrifuged, and protein concentration was determined in the supernatant by BCA Assay (Pierce). The lysate was incubated overnight at 4 C with Streptavidin-conjugated agarose beads (Sigma), equilibrated with RIPA buffer containing 1% BSA, and then washed. Proteins were eluted from the beads by incubating them in a buffer containing SDS (1%) and dithiothreitol (50 mM) for 5-8 min at 95 C. Proteins were resolved by 7.5% SDS-PAGE, transferred to a polyvinylidene difluoride (PVDF) membrane (Amersham Biosciences), and incubated in anti-CLC-3 [730] [731] [732] [733] [734] [735] [736] [737] [738] [739] [740] [741] [742] [743] [744] (1:1000). CLC-3 binding was amplified and visualized using a peroxidase-linked goat anti-rabbit IgG. Blots were developed using SuperSignal West Dura Extended Duration Kit (Pierce). To assess nonspecific streptavidin binding, some cultures were treated identically, except that the biotin was absent.
Isolation of Synaptosomal Membranes
Synaptosomal membranes and synaptic vesicles were isolated as described elsewhere (Huttner et al., 1983; Thoidis et al., 1998; Watson et al., 1994) with minor modifications. All centrifugations were carried out at 4 C. Hippocampi freshly isolated from adult rats were homogenized in an ice-cold buffer containing sucrose (0.3 M), HEPES (10 mM), and protease inhibitor cocktail (1:500, Sigma) (pH 7.3). Cell debris and nuclei were pelleted by centrifugation at 1000 3 g. The supernatant was centrifuged at 10,000 3 g for 15 min, resulting in a pellet with two visible layers. The synaptosome-rich upper layer was isolated by gentle resuspension-centrifugation in buffered sucrose containing protease inhibitors, then diluted with nine volumes of ice-cold H 2 O (hypotonic lysis in order to release synaptic vesicles from synaptosomes) and immediately homogenized with three strokes in a homogenizer. To this homogenate, 1 M HEPES (pH 7.4) was added to a final concentration of 7.5 mM and incubated on ice for 30 min to ensure synaptosome lysis. The lysate was centrifuged at 25,000 3 g for 20 min, yielding a supernatant containing synaptic vesicles and a pellet containing lysed synaptosomal membranes. The supernatant was centrifuged at 165,000 3 g for 2 hr. The resultant pellet containing synaptic vesicles was suspended in 10 mM HEPES with protease inhibitor cocktail (1:1000) and frozen at 280 C until use. To isolate synaptic membranes, the pellet containing crude lysed synaptosomal membranes was suspended in homogenization buffer, layered on top of a three-step discontinuous sucrose gradient (0.8-1.0-1.2 M), and centrifuged at w150,000 3 g for 2 hr in a swinging-bucket rotor. Purified synaptosomal membranes were found in the interface between 1.0 and 1.2 M sucrose. The sucrose concentration was diluted to 0.3 M using HEPES (10 mM), and the synaptosomal membranes centrifuged at 150,000 3 g for 45 min. The resulting pellet was resuspended in HEPES (10 mM) with protease inhibitors at 1:1000 and stored at 280 C until use.
Double Immunogold Staining and Electron Microscopy
Preparations of lysed synaptosomal membranes were fixed with 0.15% glutaraldehyde and 4% paraformaldehyde for 1 hr at 4 C, washed with PBS, and embedded in LR white resin (Electron Microscopy Science) at 45 C in a vacuum oven for 48 hr. Preparations were sectioned (90 nm) with a Reichert-Jung Ultracut E microtome. Sections were stained with anti-CLC-3 [730] [731] [732] [733] [734] [735] [736] [737] [738] [739] [740] [741] [742] [743] [744] (1:100) and mouse monoclonal antibody against postsynaptic marker . Preimmune rabbit and mouse IgG (Sigma) was used as a negative control. CLC-3 and PSD-95 were visualized using goat anti-rabbit and goat anti-mouse antibodies conjugated to 15 nm and 10 nm gold particles, respectively. Images were captured using a Tecnai F30 transmission electron microscope (TEI).
Western Blot of Hippocampal Preparations
Preparations of lysed synaptosomes and synaptic vesicles were solubilized in SDS sample buffer. Aliquots were taken for protein determination by BCA assay (Pierce), after which dithiothreitol (DTT; 50 mM) was added. Samples were heated at 65 C for 15 min and centrifuged at 14,000 3 g for 3 min. Proteins in the supernatant were resolved by SDS-PAGE and transferred to a PVDF membrane. Blots were incubated for 1 hr at room temperature or overnight at 4 C with anti-CLC-3 [730] [731] [732] [733] [734] [735] [736] [737] [738] [739] [740] [741] [742] [743] [744] (1:1000), anti-Na-K ATPase a (1:1000), or anti-synaptotagmin (1:1000). Binding was amplified with either goat anti-mouse (Promega) or donkey anti-rabbit (Amersham) secondary antibodies conjugated to horseradish peroxidase. Preimmune rabbit or mouse IgG (Sigma) was used as a negative control.
Detection was performed using Super Signal West Dura Extended Duration Substrate (Pierce).
Coimmunoprecipitation from Synaptosomal Membranes
Preparations of lysed synaptosomal membranes were incubated in RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100, 1% NP-40, 0.1% SDS, and 1 mM EDTA) containing protease inhibitors at 4 C for 40 min, then centrifuged at 14,000 3 g for 15 min. The supernatant was collected and precleared by incubation with Protein A agarose beads (Sigma) for 30 min. Proteins were incubated with anti-CLC-3 730-744 followed by incubation with Protein A agarose beads (Sigma). Beads were pelleted by centrifugation. Proteins bound to the beads were eluted by incubation in SDS/DTT sample buffer for 3 min at 95 C. The eluate (IP) and pre-IP samples were separated by SDS-PAGE with following transfer to PVDF membranes. The membrane was immunoblotted with anti-CLC-3 730-744 , anti-NR1 (1:200), anti-NR2B (1:1000), anti-PSD-95 (1:1000), or antiNa + -K + ATPase (1:1000).
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